6.3.1 PLHIV

Currently, there are no specific changes in using longer regimens in PLHIV. However, there can be cumulative risk factors for clinical complications, toxicities and drug–drug interactions (Web Annex 1 and Web Annex 2); hence, these patients may need close follow-up and support.

Book navigation